首页 > 市场调查报告书 > 医疗设备

生技设备

市场调查报告书

商品编码

1469857

全球细胞分析市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global Cell Based Assays Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年04月01日 | 出版商:

Value Market Research | 英文 234 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

预计到 2032 年，全球细胞检测市场的市场规模将从 2023 年的 209.4 亿美元达到近 381.4 亿美元，2024-2032 年研究期间复合年增长率为 6.89%。

基于细胞的测定是研究细胞过程、相互作用以及对外部刺激或化合物的反应的实验技术。它们涉及体外培养细胞并测量特定的细胞功能，例如增殖、活力、凋亡、迁移、分化或基因表现。这些检测方法广泛应用于基础研究、药物发现、毒性测试和药物筛选，以研究疾病机制、评估药物疗效和安全性以及识别潜在的治疗标靶或化合物。

市场动态

对能够准确预测药物功效、毒性和安全性的药物发现和开发工具的需求不断增长，推动了基于细胞的检测作为製药和生物技术研究中有价值的工具的采用。这些测定提供了生理相关性和生物复杂性，使得能够在更临床相关的背景下评估候选药物对细胞过程、讯号路径和疾病机制的影响。此外，细胞培养技术、自动化、影像技术和高内涵分析的进步提高了细胞检测的可扩展性、通量和重现性，使其在药物筛选、毒性测试和个人化医疗应用中不可或缺。

此外，癌症、心血管疾病和神经系统疾病等慢性疾病的流行，刺激了对基于细胞的疾病建模、标靶验证和生物标记发现检测的需求，推动了市场扩张。此外，监管机构越来越重视药物开发中的安全性和有效性评估，再加上 3D 细胞培养模型和器官晶片技术的采用，正在推动先进的细胞检测平台的创新和采用。製药公司、合约研究组织 (CRO) 和学术机构之间合作开发和验证基于细胞的检测平台推动了市场成长。此外，对精准医学和个人化治疗的投资不断增加，为患者分层和治疗优化中基于细胞的检测创造了机会。然而，来自替代检测技术的日益激烈的竞争以及对可重复性和可靠性的担忧可能会挑战未来几年的市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球细胞检测市场的每个细分市场进行了包容性评估。基于细胞的检测产业的成长和趋势为这项研究提供了整体方法。

市场区隔

基于细胞的分析市场报告的这一部分提供了有关国家和区域级别细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

依产品类型

仪器
检测试剂盒
试剂及耗材
软体
服务

按申请

药物发现
基础研究
预测毒理学
其他的

按最终用户

製药与生物技术公司
学术机构
合约研究组织
其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲的细胞检测市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。细胞侦测市场的主要参与者包括 Danaher Corporation、GE Healthcare Inc.、Charles River Laboratories、Lonza Group Ltd.、Thermo Fisher Scientific Inc.、Merck & Co、PerkinElmer Inc.、Cell Signaling Technology, Inc.、Becton 、迪金森公司、Promega 公司。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：细胞侦测公司的竞争格局

基于细胞的分析市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

顶级公司市占率分析
市场集中度
Danaher Corporation

公司简介
公司收入
产品
最近的发展

GE Healthcare Inc.

公司简介
公司收入
产品
最近的发展

Charles River Laboratories

公司简介
公司收入
产品
最近的发展

Lonza Group Ltd.

公司简介
公司收入
产品
最近的发展

Thermo Fisher Scientific Inc.

公司简介
公司收入
产品
最近的发展

Merck & Co.

公司简介
公司收入
产品
最近的发展

PerkinElmer Inc.

公司简介
公司收入
产品
最近的发展

Cell Signaling Technology Inc.

公司简介
公司收入
产品
最近的发展

Becton

公司简介
公司收入
产品
最近的发展

Dickinson And Company

公司简介
公司收入
产品
最近的发展

Promega Corporation

公司简介
公司收入
产品
最近的发展

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR112114274

The global demand for Cell Based Assays Market is presumed to reach the market size of nearly USD 38.14 Billion by 2032 from USD 20.94 Billion in 2023 with a CAGR of 6.89% under the study period 2024 - 2032.

Cell-based assays are experimental techniques for studying cellular processes, interactions, and responses to external stimuli or compounds. They involve culturing cells in vitro and measuring specific cellular functions, such as proliferation, viability, apoptosis, migration, differentiation, or gene expression. These assays are widely used in basic research, drug discovery, toxicity testing, and drug screening to investigate disease mechanisms, evaluate drug efficacy and safety, and identify potential therapeutic targets or compounds.

MARKET DYNAMICS

The escalating demand for drug discovery and development tools that can accurately predict drug efficacy, toxicity, and safety profiles drives the adoption of cell-based assays as valuable tools in pharmaceutical and biotechnology research. These assays offer physiological relevance and biological complexity, enabling the assessment of drug candidates' effects on cellular processes, signaling pathways, and disease mechanisms in a more clinically relevant context. Additionally, cell culture techniques, automation, imaging technologies, and high-content analysis advancements have improved cell-based assays' scalability, throughput, and reproducibility, making them indispensable in drug screening, toxicity testing, and personalized medicine applications.

Furthermore, the spurring prevalence of chronic diseases, such as cancer, cardiovascular disorders, and neurological conditions, has spurred the demand for cell-based assays for disease modeling, target validation, and biomarker discovery, driving market expansion. Moreover, regulatory agencies' increasing emphasis on safety and efficacy assessments in drug development, coupled with the adoption of 3D cell culture models and organ-on-a-chip technologies, is fueling the innovation and adoption of advanced cell-based assay platforms. Collaborations between pharmaceutical companies, contract research organizations (CROs), and academic institutions to develop and validate cell-based assay platforms drive market growth. Furthermore, the increasing investment in precision medicine and personalized therapeutics creates opportunities for cell-based assays in patient stratification and treatment optimization. However, increasing competition from alternative assay technologies and concerns about reproducibility and reliability may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cell based assays. The growth and trends of cell based assays industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the cell based assays market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Instruments
Assay Kits
Reagents & Consumables
Software
Services

By Application

Drug Discovery
Basic Research
Predictive Toxicology
Others

By End-User

Pharmaceutical & Biotech Companies
Academic Institutions
Contract Research Organizations
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cell Based Assays market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cell Based Assays market include Danaher Corporation, GE Healthcare Inc., Charles River Laboratories, Lonza Group Ltd., Thermo Fisher Scientific Inc., Merck & Co., PerkinElmer Inc., Cell Signaling Technology, Inc., Becton, Dickinson and Company, Promega Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. CELL BASED ASSAYS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL CELL BASED ASSAYS MARKET ANALYSIS BY PRODUCT TYPE

5.1. Overview By Product Type
5.2. Historical and Forecast Data
5.3. Analysis By Product Type
5.4. Instruments Historic and Forecast Sales By Regions
5.5. Assay Kits Historic and Forecast Sales By Regions
5.6. Reagents & Consumables Historic and Forecast Sales By Regions
5.7. Software Historic and Forecast Sales By Regions
5.8. Services Historic and Forecast Sales By Regions

6. GLOBAL CELL BASED ASSAYS MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data
6.3. Analysis By Application
6.4. Drug Discovery Historic and Forecast Sales By Regions
6.5. Basic Research Historic and Forecast Sales By Regions
6.6. Predictive Toxicology Historic and Forecast Sales By Regions
6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL CELL BASED ASSAYS MARKET ANALYSIS BY END-USER

7.1. Overview By End-user
7.2. Historical and Forecast Data
7.3. Analysis By End-user
7.4. Pharmaceutical & Biotech Companies Historic and Forecast Sales By Regions
7.5. Academic Institutions Historic and Forecast Sales By Regions
7.6. Contract Research Organizations Historic and Forecast Sales By Regions
7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL CELL BASED ASSAYS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE CELL BASED ASSAYS COMPANIES

9.1. Cell Based Assays Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF CELL BASED ASSAYS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Danaher Corporation
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. GE Healthcare Inc.
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Charles River Laboratories
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Lonza Group Ltd.
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Thermo Fisher Scientific Inc.
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Merck & Co.
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. PerkinElmer Inc.
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Cell Signaling Technology Inc.
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Becton
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Dickinson And Company
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. Promega Corporation
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments